Bulgaria Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Bulgaria Pharmaceuticals and Healthcare Report

Bulgaria Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Bulgaria Pharmaceuticals and Healthcare Report
Published Aug 27, 2016
81 pages — Published Aug 27, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Highlighting the challenges facing the country s healthcare system is the extreme difference in opinion over the trajectory of healthcare reforms, both politically and among the medical profession. Throughout the week of March -- to April -, general practitioners across the country went on strike in protest against the ---- National Framework Agreement which came into force on April -, claiming that some decisions harm the interests of doctors as well as patients. ...Highlighting the challenges facing the country s healthcare system is the extreme difference in opinion over the trajectory of healthcare reforms, both politically and among the medical profession. Throughout the week of March -- to April -, general practitioners across the country went on strike in protest against the ---- National Framework Agreement which came into force on April -, claiming that some decisions harm the interests of doctors as well as patients. In contrast, the Association of University Hospitals in Bulgaria sought to distance itself from the striking activities. Moreover, the Chairperson of the National Association of Medical Workers in Emergency Medical Aid Centres stated that the reforms to healthcare over the past year have been on the right track and have definitely solved problems in the emergency medical aid . On March -- ----, Minister of Health Petar Moskov announced that an extra BGN--mn (USD-.-mn) will be allocated to the National Health Insurance Fund budget to guarantee that --- of patients with oncological diseases will be treated in ----.

...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued The government s programme to shift costs to the private sector to potentially result in a decline in pharmaceutical consumption, as the financial burden on the public increases. Counterfeit drugs continuing to pose a threat to the pharmaceutical revenues of original products. High level of corruption and political uncertainty to continue to deter some foreign investors. Application of pharma co-economic guidelines to curb extensions of positive reimbursement list and cap price levels of drugs. Mismanagement of publicly-funded healthcare system. ...Mismanagement of publicly-funded healthcare system. Price-freezing on consumer pharmaceuticals to hurt growth of consumer healthcare companies.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...

  
Source:
Document ID
1748-1805
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
CONTENTS43
Executive Summary72
SWOT Analysis93
Pharmaceutical Risk/Reward Ratings123
  Rewards131
  Risks132
Bulgaria Market Summary1514
  Regulatory Regime161
  Pharmaceutical Advertising171
  Intellectual Property Environment181
  Trademark Disputes191
  Pricing Regime201
  Drug Policy Amendments Passed In 2011211
  Drug Policy Amendments For 2012221
  Legislative Changes To Drug Policy In 2013 And Beyond233
  Reimbursement Regime261
  Reimbursement Regime Developments272
Industry Developments2911
  Epidemiology291
  Communicable Diseases301
  Healthcare Sector311
  Healthcare Insurance321
  Healthcare Reform Through To 2020332
  Healthcare Financing351
  Research &Development362
  Clinical Trials381
  Medical Devices391
Industry Forecast Scenario406
  Pharmaceutical Market Forecast403
  Healthcare Market Forecast433
Macroeconomic Forecast Scenario4621
  Prescription Drug Market Forecast495
  Patented Drug Market Forecast542
  Generic Drug Market Forecast562
  OTC Medicine Market Forecast583
  Pharmaceutical Trade Forecast612
  Medical Device Market Forecast632
  Other Healthcare Data651
  Key Risks To BMI s Forecast Scenario661
Competitive Landscape674
  Pharmaceutical Industry671
  Company Activities681
  Wholesale Sector691
  Retail Sector692
Company Profiles7116
  Local Companies717
  Multinational Companies789
Glossary872
BMI Methodology894
  How We Generate Our Pharmaceutical Industry Forecasts894
    Pharmaceutical Risk/Reward Ratings Methodology901
    Ratings Overview902
    Weighting921
    Sources921

Table Of Contents

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Bulgaria Pharmaceuticals and Healthcare Report" Aug 27, 2016. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Bulgaria-Pharmaceuticals-and-Healthcare-Report-2026-283>
  
APA:
Business Monitor International - Industry Reports. (2016). Bulgaria Pharmaceuticals and Healthcare Report Aug 27, 2016. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Bulgaria-Pharmaceuticals-and-Healthcare-Report-2026-283>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.